NCT06231121已完成不适用
Short-term Results With Faricimab After Multiple Sequential Treatment Switches Due to Resistance With Both Aflibercept and Ranibizumab in Neovascular Age-related Macular Degeneration
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
- 试验地点
- 1
- 主要终点
- Proportion of patients responding to the treatment switch
研究概览
简要总结
The goal of this retrospective single-center chart review is to establish the response rate, efficacy and safety of a single dose of intravitreal faricimab injection in real-world patients with aflibercept- and ranibizumab-resistant neovascular age-related macular degeneration.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Patients
Patients who received intravitreal faricimab injections between May and September, in 2023. and conform the inclusion/exclusion criteria.
干预措施: Faricimab (Drug)
结局指标
主要结局
Proportion of patients responding to the treatment switch
时间窗: 4 weeks
Defined as reduction or disappearance of the intra- or subretinal fluid at 4 weeks following a single injection of faricimab
次要结局
- Differences in patient characteristics between individuals responding and not responding to faricimab(4 weeks)
- Changes in central retinal thickness after the treatment switch(4 weeks)
- Changes in best-corrected visual acuity after the treatment switch(4 weeks)
- Changes in pigment epithelium detachment (PED) height after the treatment switch(4 weeks)
研究者
Miklos Schneider MD, PhD
Staff Specialist
Rigshospitalet, Denmark
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)Wet Macular DegenerationNCT03823300Hoffmann-La Roche658
已完成
3 期
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)Wet Macular DegenerationNCT03823287Hoffmann-La Roche671
已完成
1 期
Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy VolunteersHealthyNCT01147055Pfizer15
招募中
4 期
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)Polypoidal Choroidal VasculopathyNCT06709339Association for Innovation and Biomedical Research on Light and Image120
已完成
2 期
Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK ArteriesPeripheral Arterial DiseaseNCT01630070Flanders Medical Research Program70